NCT05537831

Brief Summary

This is a randomized control trial comparing the efficacy of ultrasound (US) guided vs landmark-guided hematoma blocks on distal forearm fractures.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

September 2, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 13, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

September 13, 2022

Status Verified

September 1, 2022

Enrollment Period

1 year

First QC Date

September 2, 2022

Last Update Submit

September 9, 2022

Conditions

Keywords

UltrasoundHematoma block

Outcome Measures

Primary Outcomes (1)

  • Pain relief from landmark versus ultrasound guided hematoma block

    Pain will be measured using a ten point Likert scale with zero designated as no pain and ten being the worst pain the patient can imagine. The higher score the worse the outcome.

    Change in pain score from before the hematoma block to immediately after the reduction/splinting of the forearm fracture

Study Arms (2)

Study Intervention Group (Ultrasound)

ACTIVE COMPARATOR

The ultrasound probe will be used for real-time needle and hematoma localization using the linear probe. The hematoma block will then be performed with aseptic technique. The skin will be prepped with chlorhexidine. A 20-gauge needle will be inserted in-plane into the hematoma site. A small amount of blood will be aspirated to confirm placement and 5-10 mL of 1% lidocaine will be infiltrated.

Device: Ultrasound

Study Control Group (Landmark)

NO INTERVENTION

The ultrasound probe will be in place on the patient's arm to maintain single blinding of the study. The ultrasound machine will not be used for needle and hematoma localization. The hematoma block will then be performed with aseptic technique. The skin will be prepped with chlorhexidine. A 20-gauge needle will be inserted in-plane into the hematoma site. A small amount of blood will be aspirated to confirm placement and 5-10 mL of 1% lidocaine will be infiltrated.

Interventions

The ultrasound will be used to assist with the delivery of a hematoma block in patients with distal forearm fractures.

Study Intervention Group (Ultrasound)

Eligibility Criteria

Age7 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients greater than and equal to seven years of age
  • Patients with traumatic acute distal radius/ulnar fractures with displacement that require reduction and immobilization with splinting
  • Patients that receive distal radius hematoma blocks, including those who require additional pain control adjuncts if pain control is not adequate

You may not qualify if:

  • Prisoners
  • Pregnant women
  • Patients with altered mental status/have impaired decision-making capacity.
  • Patients with allergies to amide anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Ultrasonography

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Central Study Contacts

Paul Klawitter, MD

CONTACT

Jerome Hoke, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Profressor

Study Record Dates

First Submitted

September 2, 2022

First Posted

September 13, 2022

Study Start

September 1, 2022

Primary Completion

September 1, 2023

Study Completion

December 1, 2023

Last Updated

September 13, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share